Fruit fly gene study could yield new flu treatments

July 10, 2008

As they design new drugs to fight off influenza, scientists may not need to attack the virus directly. Instead, they may be able to stave off infection by targeting one of more than 100 proteins inside host cells on which the virus depends.

These potential drug targets are the result of a study in which scientists, led by Howard Hughes Medical Institute investigator Paul Ahlquist and colleague Yoshihiro Kawaoka at the University of Wisconsin-Madison, tested the ability of a modified influenza virus to infect fruit fly cells. "Our findings give us considerable hope that-with a large number of host targets to choose from-we could develop drugs to more stably suppress the virus and not allow the virus to evolve nearly as quickly to generate resistance," Ahlquist said. The team described their findings in a July 9, 2008, advance online publication of the journal Nature.

Viruses possess only a limited number of genes, so they must hijack a host cell's own protein machinery to enter the cell and replicate their genes. Relatively few of influenza's interactions with host proteins are understood, according to Ahlquist, and this has limited drug development.

"So far, antiviral treatments against influenza have targeted specific viral enzymes or functions," he said. "The problem has been that the virus can mutate itself to develop resistance to these drugs. Our hope is that by identifying host functions on which the influenza virus depends, we can develop drugs that target these functions. And since those functions are encoded by the host, the virus cannot use simple mutations to develop resistance to such drugs."

Although fruit flies are not naturally infected by the influenza virus, Ahlquist and his colleagues knew the fly would be a powerful tool in identifying the genes and proteins that facilitate infection. A great many fly genes have counterparts in humans, and the researchers could analyze the function of individual fly genes using a technique known as RNA interference. So the researchers genetically altered influenza virus so that it could infect cultured fruit fly cells grown in the laboratory. They also added a gene that would produce a telltale fluorescence when the virus successfully replicated in fly cells.

They next used RNA interference -- treating fly cells with small snippets of RNA -- to individually suppress the function of each of 13,071 genes, representing 90 percent of all fly genes. If a gene is important for allowing the virus to replicate, fly cells in which that gene had been shut off would not emit the fluorescent signal signifying infection. Using this screen, the researchers identified more than 100 host cell genes that the virus depended on for infection.

"We found that the virus depends on the function of fly genes in a wide range of cellular processes," said Ahlquist. "This tells us that quite a variety of host functions are important to the virus and that there could be a broad range of options for antiviral drugs."

The researchers wanted to be sure that their findings were relevant for influenza infections that occur outside of the laboratory. So, as an initial check, they tested the ability of natural strains of the virus to infect mammalian cells lacking three of the genes they had identified in the fruit fly cells. The genes they chose participate in three different cellular processes known to be involved in the life cycle of the virus. They found that suppressing the function of any of the three diverse genes-called ATP6V0D1, COX6A1 and NXF1-thwarted viral replication.

The researchers also tested how blocking these genes might affect infection with other viruses, and found that all three genes were influenza-specific. Suppressing them did not affect replication of two other viruses they tested. Thus, said Ahlquist, the influenza virus functions in a way that is distinct from the other viruses and that may offer a prime target for influenza-specific antiviral drugs.

Howard Hughes Medical Institute

---

---

	Swine influenza Pandemic H1N1/09 virus by Lulu.com Swine influenza Pandemic H1N1/09 virus Time is short. "Clearly this will drill down to states and, frankly, local health departments," she said. "We have got to push supplies out. We have got to push antivirals out." No one knows if the H1N1 virus will stay mild, or if it will change slightly as it circulates, coming back in the northern hemisphere's autumn months in a more virulent form. SURGE CAPACITY Hospitals must prepare their so-called surge capacity -- making room to take in dozens or even hundreds of sick people at once -- at a time when most hospitals are already full with day-to-day sicknesses and emergencies.
	Avian influenza viruses may spark next pandemic.(News): An article from: Family Practice News by Michele G. Sullivan (Author) This digital document is an article from Family Practice News, published by International Medical News Group on September 15, 2004. The length of the article is 673 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Avian influenza viruses may spark next pandemic.(News) Author: Michele G. Sullivan Publication: Family Practice News (Magazine/Journal) Date: September 15, 2004 Publisher: International Medical News Group Volume: 34 Issue: 18 Page: 9(1) Distributed by Thomson...
	Influenza Virus Sialidase - A Drug Discovery Target (Milestones in Drug Therapy) by Mark von Itzstein (Editor) Influenza continues to be an ongoing problem despite the existence of vaccines and drugs. Disease outbreaks can occur relatively quickly as witnessed with the recent emergence of the influenza virus A/H1N1 pandemic. The development of new anti-influenza drugs is thus a major challenge. This volume describes all aspects of the virus structure and function relevant to infection. The focus is on drug discovery of inhibitors to the enzyme sialidase, which plays a key role in the infectious lifecycle of the virus. Following an overview of the influenza virus, the haemagglutinin, the interactions with the cell receptors and the enzymology of virus sialidase, recent results in drug design are presented. These include a full coverage of the design, synthesis and evaluation of carbohydrate as...
	Avian Influenza Virus (Methods in Molecular Biology) by Erica Spackman (Editor) With the growing global fear of a major pandemic, avian influenza (AI) virus research has greatly increased in importance. In Avian Influenza Virus, an expert team of researchers and diagnosticians examine the fundamental, yet essential, virological methods for AI virus research and diagnostics as well as some of the newest molecular procedures currently used for basic and applied research. They present exciting, cutting-edge new methods that focus both on studying the virus itself and on work with avian hosts, an area greatly lacking in research.
	Structure and Variation in Influenza Virus: Workshop Proceedings (Developments in cell biology) by Graeme Laver (Editor), Gillian Air (Editor)
	Influenza Virus: Methods and Protocols (Methods in Molecular Biology) by Yoshihiro Kawaoka (Editor), Gabriele Neumann (Editor)
	The Return of the Spanish Lady: The 1918 Influenza Virus is Back by Alain Normand (Author) In book one of the Lakedge Disaster Series, Josh Stuart is a family man with firm principles and strong values. But when a stranger rides into the quiet town of Lakedge bringing fear, division and death, Josh, his family, indeed the whole town are forever changed. They eventually realise that this Spanish Lady has remained hidden for almost a century. The last time she was out in 1918, she rampaged through the world taking more than 20 million lives. Now she is out of hibernation, she is on the hunt, she is hungry for blood. Her next stop just happened to be... Lakedge.
	The Origin of Pandemic Influenza Viruses (Proceedings of the International Workshop China 1982) by Laver (Author)
	100 Questions & Answers About Influenza by Delthia Ricks (Author) Every year in the United States, on average 5% to 20% of the population becomes sick with influenza (the flu); more than 200,000 people are hospitalized from flu complications, and about 36,000 people die from flu. Some people - such as older people, young children, and people with certain health conditions - are at high risk for serious flu complications. 100 Questions and Answers About Influenza provides answers to 100 most common questions about influenza, with emphasis on new strains of the disease including the Avian Influenza.
	Influenza Virology: Current Topics by Yoshihiro Kawaoka (Editor) Three times in the last century, influenza viruses have undergone major genetic changes resulting in global pandemics that had devastating effects. The most infamous pandemic was the "Spanish Flu" which affected up to 25% of the world population and is thought to have killed at least 40 million people. In 1997 and 2003, a new influenza A virus of H5N1 subtype emerged in Asia and was transmitted directly from birds to humans with lethal outcomes. Despite monumental efforts to contain them, the H5N1 viruses expanded their territory and caused a major outbreak in wild waterfowl in China in 2005. Despite extensive, coordinated efforts by various agencies and disciplines, both national and international, we are ill-equipped for a new influenza pandemic. In fact, it is highly unlikely that...